https://www.selleckchem.com/products/pri-724.html
the US represents approximately $94.9 billion. Restless legs syndrome (RLS) is a common neurological disorder characterized by an uncontrollable nocturnal urge to move the legs and often associated with chronic sleep disturbances. The most common treatments for RLS are medications that can have debilitating side-effects. Here, we evaluated a novel alternative modality of RLS treatment, noninvasive bilateral electrical stimulation of the common peroneal nerve. To assess the impact of this noninvasive peripheral nerve stimulation (NPNS) a